Valencia, Calif-based Bioness and Germany-headquartered Ottobock have forged a strategic partnership to expand the distribution and access of functional electrical stimulation (FES) technologies in the European Union, UK, Switzerland, Norway, Turkey, and India.
“Our partnership with Ottobock opens up significant opportunity for both organizations,” says Todd Cushman, president & CEO of Bioness, in a media release. “Our leading technology position in functional electrical stimulation, highlighted by the recent clearance of the L300 Go System by US FDA and CE Mark, combined with Ottobock’s resources, reputation and market reach, creates an extremely powerful synergy.”
“Since 2005 Ottobock has been offering functional electrical stimulation device solutions as part of their mobility after stroke concept for healthcare providers and patients,” states Frank Bömers, Global Head of Orthotics for Ottobock, per the release. “Our strategic partnership with Bioness reinforces our commitment to the technology platform and allows Ottobock to leverage our resources to expand product access and affordability.”
Starting in September 2017, Ottobock will begin product commercialization within its Orthotics Division and will distribute Bioness’ complete FES portfolio for the lower (L300 Go System) and upper extremities (H200 Wireless System).
[Source(s): Bioness Inc, PR Newswire]
